Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Robert Ford
Person

Robert Ford

Tracked across 2 events · 26 articles · First seen Apr 02, 2026 · Last active Aug 21, 2026

Sentiment
-15
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 -10
Business
Abbott settles preterm formula NEC lawsuits
Abbott Laboratories agreed to pay $670 million to settle a portion of the litigation alleging that its preterm infant formulas cause necrotizing enterocolitis (NEC), a deadly bowel disease. The settlement, announced on August 21, 2026,…
Impact: As CEO of Abbott, Robert Ford has been involved in the litigation strategy, previously suggesting the products might be pulled from the market. The settlement may alleviate some pressure on him.
Aug 20, 2026 · 20 articles
4 -20
Business
Abbott Laboratories $70M NEC Verdict
Impact: Robert Ford, CEO of Abbott Laboratories, suggested that preterm products might become unavailable due to the litigation, highlighting the potential long-term impact of these lawsuits on the company's product offerings.
Apr 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Robert Ford live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.